Portfolio
13
Fund Size
—
Top Stage
Seed
Last 12 Mo
2
Stage Distribution
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Neurophos | Series A | $110M | Jan 2026 |
| Formulary Financial | Seed | $4.6M | Jan 2026 |
| PAXAFE | Series A | $9M | May 2024 |
| Unnatural Products, Inc. | Series A | $32M | Dec 2023 |
| Pepper Bio | Seed | $6.5M | Nov 2023 |
| GoodBuy Gear | Series A | $14M | Jun 2023 |
| Capsule | Seed | $4.8M | Jan 2023 |
| Whoosh, Inc. | Seed | $6M | Jan 2022 |
| Gross-Wen Technologies | Series A | $6.5M | Aug 2021 |
| Lootcakes | Seed | $2M | Aug 2020 |
| Valence | Seed | $2.5M | Nov 2019 |
| Grifin | Unknown | — | — |
| Bedrock Ocean | Series A | $25M | — |
Top Co-Investors
M12 (Microsoft)2 shared
Khosla Ventures1 shared
GGV Capital1 shared
Craft Ventures1 shared
NFX1 shared
Bloomberg Beta1 shared
Primary Venture Partners1 shared
Northzone1 shared
Costanoa Ventures1 shared
Felicis Ventures1 shared
Upfront Ventures1 shared